Telangana Bans Almont Kid Syrup Over Safety Concerns
Telangana bans Almont Kid Syrup after a central safety alert. Learn about the risks, the government's directive, and crucial steps for parents to ensure child safety.
Category : Search result: CDSCO regulation
Telangana Issues 'Stop Use' Notice for Almont-Kid Syrup
Telangana's Drugs Control Authority has advised the public to immediately stop using Almont-Kid Syrup and report it to authorities following a CDSCO alert. Safety first.
Telangana Bans Almont-Kid Syrup Over Toxic Contamination
Telangana DCA issues urgent alert to stop using Almont-Kid Syrup for children after CDSCO lab finds it adulterated with toxic Ethylene Glycol. Check batch numbers now.
Telangana Bans Almont-Kid Syrup Over Toxic Contamination
Telangana DCA issues urgent advisory to stop using Almont-Kid Syrup for children after finding toxic Ethylene Glycol. Check batch numbers and report possession immediately.
Telangana bans Almont Kid Syrup over contamination risk
Telangana bans Almont Kid Syrup after CDSCO alert finds contamination. Health officials order recall from all pharmacies. Parents urged to check medicine.
Delhi extends deadline for school fee regulation panels
Delhi High Court grants schools more time to set up fee committees and submit hike proposals. The court refuses to stay the new fee regulation law, seeks response from DoE and LG. Next hearing on March 12.
India Plans OTC Antibiotics Ban to Curb AMR Crisis
India's drug regulator proposes a major overhaul, including a ban on OTC antibiotic sales and an R&D push, to tackle antimicrobial resistance causing 267,000 deaths annually. Read the full plan.
Delhi HC: No Stay on New Private School Fee Law
Delhi High Court refuses to stay new fee regulation law for private schools but extends deadlines. Committees must be formed by Jan 20. Key details inside.
Govt Brings AI Cancer Detection Software Under Regulation
India's CDSCO now regulates AI-based cancer detection software as Class C medical devices, requiring approval and safety validation. Experts call the move timely for patient safety. #Healthcare #AI #India
Govt Rolls Out New Rules to Settle Minor Drug Violations
India introduces a formal mechanism for drug and medical device firms to settle minor regulatory violations by paying fines, aiming to reduce court burdens and focus on serious health risks. Learn how the new compounding rules work.
India Bans Nimesulide for Under-18s Over Safety Risks
India bans Nimesulide for those under 18, citing liver damage risks. This crucial step highlights the need for stricter drug regulation to protect public health. Read more.
6mg Nicotine Pouches Seek Approval in India
Indian firms seek CDSCO nod to sell high-strength 6mg nicotine pouches as NRT, sparking fears of youth initiation and addiction. Experts warn of cardiovascular risks.
Drug Inspection Data Kept Secret, Public Safety at Risk?
India's drug regulator CDSCO refuses to disclose risk-based inspection details under RTI, sparking debate on transparency vs. commercial interests. Experts warn this secrecy endangers public health.
India's drug regulator cancels import licence of QR678 Neo
India's drug regulator CDSCO cancels the import licence of hair-loss product QR678 Neo for making false therapeutic claims while registered as a cosmetic. Learn the details and regulatory implications.
Govt Mulls 1-Year Extension for Pharma GMP Norms
The Indian government considers a one-year extension for MSMEs to comply with revised Schedule M GMP norms, aiming to prevent plant closures and safeguard its $50 billion pharma sector. Read more.
India's Digital Regulation Gap: Impact on Consumers
With no law to regulate digital services, what does India's regulatory gap mean for competition and your digital rights? Mozilla explains the need for tailored rules.
New CDSCO Rules for Solvent Labels After Child Deaths
India's drug regulator CDSCO mandates new labelling rules for solvent makers to prevent toxic chemicals from entering medicines. This follows the tragic deaths of at least 25 children in Madhya Pradesh. Read the full story.
Delhi Schools Get Jan 10 Deadline for Fee Panels
Delhi's Directorate of Education mandates all private schools to set up School Level Fee Regulation Committees by January 10, 2026. This historic move under a new law gives parents a direct say in fee hikes.
Delhi Govt Rolls Out New Fee Regulation for Private Schools
The Delhi government has introduced a new fee regulation framework for private schools, aiming to ensure transparency and prevent arbitrary hikes. Learn how this impacts parents and institutions.
Medical Smartwatches Drive India's $4.2B Wearable Health Market
Smartwatches evolve from fitness trackers to certified health devices in India. With Apple & Samsung leading, the medical wearable market is projected to hit $4.2 billion by 2033. Read more.
Govt's Data Exclusivity Push May Hit Cheap Generic Drugs
The Indian government is considering data exclusivity for pharma, a move that could delay cheap generic drugs, impact India's global edge, and affect medicine access. Read the full analysis.
Himachal Leads Nation in Substandard Drugs: 49 Fail
Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.
49 Himachal drug samples fail quality tests, recall ordered
Himachal drug controller directs firms to recall stock after 49 medicine samples fail quality tests. Substandard drugs include medication for fever, heart attacks, and diabetes. Learn which medicines to avoid.
The Scientific Bottlenecks Causing Slow Drug Approvals in India
India's drug approval process faces delays due to complex scientific hurdles in translational research. Experts explain the challenges and propose solutions for faster patient access to new treatments.
India Plans Perpetual Licenses for Medical Devices
India plans to replace 5-year medical device licenses with perpetual approvals and standardize lab testing to cut compliance costs and attract investment. Read more.
India's First AI-Based Smart Hemodialysis Machine Licence
Lords Mark Industries secures CDSCO licence for Class C AI Hemodialysis Machines, a major step for India's med-tech self-reliance. Read how this innovation impacts renal care.
Himachal Pharma Sector Faces Major Trust Crisis
Himachal Pradesh's pharmaceutical hub is in turmoil as 38 firms lose WHO-GMP certification, raising serious quality concerns. Discover the causes and impact.
QR Codes in Pharmacies to Boost India's Drug Safety Reporting
India mandates QR codes in all pharmacies for instant reporting of medicine side effects. This move aims to transform pharmacovigilance and make drug safety a public responsibility. Scan and report!
Bombay HC Seeks Expert Report on Cancer Vaccine Trial Plea
Bombay High Court directs a CDSCO expert committee to review Datar Cancer Genetics' plea for human trials of its Per-C-Vax cancer immunotherapy. The panel must submit its report within three months. Read the full details.
HIV Prevention Drug Blocked for Indians Despite Local Manufacturing
India's drug regulator CDSCO refuses to waive local trials for lenacapavir, blocking access to revolutionary HIV prevention for 25 lakh Indians. Learn why this happens despite drug being manufactured in India.
Page 1 of 4